Moderna discards 30 Million Doses of COVID-19 Vaccine, no country want’s them!

On May 25, 2022 at the WEF it was reported that Stéphane Bancel, Moderna's CEO, while on a discussion panel said: [1, 2] “It’s sad to say, I’m in the process of throwing 30 million doses into the garbage, because nobody wants them,” “We have a big demand problem.” Bancel elaborated on the outreach efforts the pharma giant was making to “every country,” including going around to all the embassies in Washington, D.C., to entreat governments to distribute the excess shots to their citizens. But sadly, he concluded, “nobody wants to take them.” “The problem we had two years ago is there was no mRNA capacity in the world. Zero.” [today] “Moderna has 3 billion doses annual capacity, Pfizer has 4 billion doses, that’s seven billion doses, and the Chinese don’t want the vaccines with mRNA. So if you just take the, just the Chinese population out, you have more than a dose per person, and as we just discussed, the issue in many countries is people don’t want vaccines." "We don't have a capacity issue, it was true 2 years ago, it is not true today" Remember this 2016 prophecy by the man who worked with and funded the..> READ MORE

“Classical” herd immunity may not be attainable for COVID-19

On March 21, 2022, Dr Anthony Fauci et al published a paper to further propagate the notion  that "classical herd immunity" may not be "attainable" for COVID-19.  "The authors explain how the scientific understanding of herd immunity and its applications to various diseases have evolved over time." [1] Some factors that Dr Fauci et al believe hinder achieving herd immunity for SARS-CoV-2 include: "the virus’ ability to continually mutate to new variants; asymptomatic virus transmission, which complicates public health control strategies; the inability of prior infection or vaccination to provide durable protection against reinfection; suboptimal vaccination coverage; and adherence to non-pharmacologic interventions." "Research to develop pan-coronavirus vaccines, which could protect against multiple coronaviruses or at least multiple SARS-CoV-2 variants, remains crucial."  Remember in March 2020 getting a vaccine was the only way, this is the next step!  [2] Ten days later, on March 31st, the NIH launched their clinical trials for mRNA multi-variant vaccines; a solution they'll likely come to promote!